Bliss GVS Pharma
BLISSGVS · Pharma > Pharmaceuticals & Drugs · Chairman: S R Vaidya · MD: Gagan Harsh Sharma · Listing date: July 26, 2010 · Employees: 683 · Mumbai · http://www.blissgvs.com

Stock Price vs Company Growth
1d
4.2%
1w
6.2%
1m
7.2%
3m
35.1%
6m
149.6%
1y
316.4%
5y
42.9%
10y
16.5%
all
19.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 631 4.2%
441
745
Company Overview

Sales
1,005 Cr
Growth: 13.6%
Profit after Tax
136 Cr
Growth: 5.5%
Small Cap
6,715 Cr
P/E: 50.1x
Industry P/E: 32.5x
Fundamentals

Sales (Cr) ₹ 1,005
Growth 13.6%
EBITDA 18.6%
P/S 6.7x
Dividend 0.5%
P/E 50.1x
Book Value ₹ 117
PEG Ratio 3.8x
ROE 11.6%
P/B 5.6x
Shareholding Pattern

Institutions
Arian Investment Ltd
9.7 %
Life Insurance Corporation Of India
6.68 %
Polus Global Fund
4.62 %
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund
2.9 %
Aspire Emerging Fund
2.46 %
Promoters
Narsimha Shibroor Kamath
33.24 %
Others
Gulbarga Trading And Investment Pvt. Ltd.
5.67 %
Arjun Gautam Ashra
4.89 %
Gautam Rasiklal Ashra
2.82 %
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs
2.2 %
Llp
0.05 %
Increase    Decrease    No change
Company Profile Detailed

It is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. The company’s most unique product is ‘Today Vaginal Contraceptive’, a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception.
Investors (66)
Followers (10)